Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Metastatic prostate cancer with normal level of serum prostate-specific antigen

By Nishio R.   Furuya Y.   Nagakawa O.   Fuse H.  

International Urology and Nephrology, Vol. 35, Iss. 2, 2003-01 ,pp. : 189-192

Springer Publishing Company

Access to resources Recommend Favorite

Biologic variability of prostate-specific antigen and its usefulness as a marker for prostate cancer: effects of finasteride

By Oesterling J.E.   Roy J.   Agha A.   Shown T.   Krarup T.   Johansen T.   Lagerkvist M.   Gormley G.   Bach M.   Waldstreicher J.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 13-18

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration

By Monda J.M.   Myers R.P.   Bostwick D.G.   Oesterling J.E.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 62-64

Elsevier

Access to resources Recommend Favorite